Adherence in hypertension: a review of prevalence, risk factors, impact, and management

M Burnier, BM Egan - Circulation research, 2019 - Am Heart Assoc
The global epidemic of hypertension is largely uncontrolled and hypertension remains the
leading cause of noncommunicable disease deaths worldwide. Suboptimal adherence …

Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal …

C Zoccali, F Mallamaci, M Adamczak… - Cardiovascular …, 2023 - academic.oup.com
Chronic kidney disease (CKD) is classified into five stages with kidney failure being the most
severe stage (stage G5). CKD conveys a high risk for coronary artery disease, heart failure …

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

G Mancia, R Kreutz, M Brunström, M Burnier… - Journal of …, 2023 - journals.lww.com
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Risk factors for CKD progression: overview of findings from the CRIC study

M Hannan, S Ansari, N Meza… - Clinical Journal of the …, 2021 - journals.lww.com
Abstract The Chronic Renal Insufficiency Cohort (CRIC) Study is an ongoing, multicenter,
longitudinal study of nearly 5500 adults with CKD in the United States. Over the past 10 …

A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider

SM Hamrahian, OH Maarouf, T Fülöp - Patient preference and …, 2022 - Taylor & Francis
Hypertension is a global public health problem, and its prevalence is increasing worldwide.
Impacting all human societies and socioeconomic strata, it remains the major modifiable risk …

Adherence to oral antidiabetic drugs in patients with type 2 diabetes: systematic review and meta-analysis

E Piragine, D Petri, A Martelli, V Calderone… - Journal of Clinical …, 2023 - mdpi.com
Poor adherence to oral antidiabetic drugs (OADs) in patients with type 2 diabetes (T2D) can
lead to therapy failure and risk of complications. The aim of this study was to produce an …

[PDF][PDF] 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of …

M Brunström, M Burnier… - Journal of …, 2023 - docred-strapi-cms-prod.s3.sa-east-1 …
Document Reviewers: Luis Alcocer (Mexico), Christina Antza (Greece), Mustafa Arici
(Turkey), Eduardo Barbosa (Brazil), Adel Berbari (Lebanon), Luıs Bronze (Portugal), John …

Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature

JJB Seng, JY Tan, CT Yeam, H Htay… - International urology and …, 2020 - Springer
Background Medication adherence plays an essential role in slowing the progression of
chronic kidney disease (CKD). This review aims to summarise factors affecting medication …

Synbiotics easing renal failure by improving gut microbiology II (SYNERGY II): a feasibility randomized controlled trial

C McFarlane, R Krishnasamy, T Stanton, E Savill… - Nutrients, 2021 - mdpi.com
Synbiotics have emerged as a therapeutic strategy for modulating the gut microbiome and
targeting novel cardiovascular risk factors, including uremic toxins indoxyl sulfate (IS) and p …

Medication non-adherence in chronic kidney disease: a mixed-methods review and synthesis using the theoretical domains framework and the behavioural change …

WH Tesfaye, D Erku, A Mekonnen, YG Tefera… - Journal of …, 2021 - Springer
Objective Medication non-adherence is a well-recognised issue in chronic diseases but data
in patients with chronic kidney disease (CKD) not receiving kidney replacement therapy …